Logo
x

Search

Subscribe Now

First-in-Human

reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

reMYND Commences P-l Study of RES19-T for Alzheimer's Disease

  • December 4, 2020
Celltrion Anticipates the Initiation of its First-in-Human Clinical Studies Targeting COVID-19 in July

Celltrion Anticipates the Initiation of its First-in-Human Clinical Studies Targeting COVID-19 in July

  • April 14, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.